Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Aethlon Medical, Inc.
Aethlon Medical Nears Completion of First Medical Device Study to Treat HIV/AIDS
January 30th, 2009
Aethlon Medical, Inc. (OTCBB:AEMD) announced that it is nearing completion of the “first-in-man” study of a medical device to treat Human Immunodeficiency Virus (HIV), the disease that causes Acquired Immune Deficiency Syndrome (AIDS). In the study, an HIV-infected individual recently initiated treatment with the Aethlon Hemopurifier® as part of a 30-day case study being conducted at the Jattinder Gambhir Hospital (J.G. Hospital) in Punjab, India. The study protocol, which calls for the administration of up to twelve Hemopurifier® treatments, is scheduled to be completed on January 23rd. The study goal is to demonstrate that the Hemopurifier® can safely and effectively reduce viral load...
Source: Health Business Week (2009-01-30)
|
